Document:

Exhibit 10.5

 

Schedule of Parties to Termination of Restated Stock Transfer Restriction Agreement (RSTRA) as of March 12, 2012

 

	
Stockholder
    	
 
    	
Legacy Class A
   Common Stock
   Subject to RSTRA
   (pre-split)
    	
 
    
	
Robert   P. Acheson
    	
 
    	
675
    	
 
    
	
Peter   C. Adams
    	
 
    	
145
    	
 
    
	
Amy   Pratt Alexander, Trustee of the Amy Alexander Trust dtd 6/20/07
    	
 
    	
6,000
    	
 
    
	
Amy   Pratt Alexander as Trustee of the Logan Neil Alexander Trust dtd 12/23/10
    	
 
    	
103
    	
 
    
	
Amy   Pratt Alexander as Trustee of the Aidan Pratt Alexander Trust dtd 12/23/10 
    	
 
    	
103
    	
 
    
	
Amy   Pratt Alexander as Trustee of the Quinn Emmett Alexander Trust dtd 12/23/10
    	
 
    	
103
    	
 
    
	
Frank   Alvarez
    	
 
    	
1,145
    	
 
    
	
Debra   M. Amens
    	
 
    	
171
    	
 
    
	
Stephen   E. Babson
    	
 
    	
931
    	
 
    
	
Kurt   M. Ball
    	
 
    	
6
    	
 
    
	
David   K. Bancroft
    	
 
    	
297
    	
 
    
	
Francois   R. Baril
    	
 
    	
1,709
    	
 
    
	
Peter   F. Bechen
    	
 
    	
1,358
    	
 
    
	
Ian   R. Bingham
    	
 
    	
404
    	
 
    
	
Eric   A. Blackburn
    	
 
    	
171
    	
 
    
	
Terry   L. Briscoe
    	
 
    	
744
    	
 
    
	
Christopher   M. Carpenter
    	
 
    	
616
    	
 
    
	
Calvin   W. Collins
    	
 
    	
2,605
    	
 
    
	
James   V. Corso
    	
 
    	
1,711
    	
 
    
	
Angela   Shawn Cunningham, Trustee of the Angela Cunningham Trust dtd 6/20/07
    	
 
    	
6,000
    	
 
    
	
Angela   Shawn Cunningham, Trustee of the Cade Steven Cunningham Trust dtd 12/12/10
    	
 
    	
103
    	
 
    
	
Angela   Shawn Cunningham, Trustee of the Avery Lynn Cunningham Trust dtd 12/12/10 
    	
 
    	
103
    	
 
    
	
Angela   Shawn Cunningham, Trustee of the Paige Ryan Cunningham Trust dtd 12/12/10
    	
 
    	
103
    	
 
    
	
Richard   E. Dale
    	
 
    	
17
    	
 
    
	
Daniel   P. Devlin
    	
 
    	
985
    	
 
    
	
John   R. Dillon
    	
 
    	
1,242
    	
 
    

 

 

	
Paula   M. Disney
    	
 
    	
470
    	
 
    
	
William   K. Douglas
    	
 
    	
148
    	
 
    
	
Nadia   R. Drakos
    	
 
    	
43
    	
 
    
	
Timothy   J. Elbel
    	
 
    	
1,628
    	
 
    
	
David   K. Ellas
    	
 
    	
514
    	
 
    
	
James   M. Ewing
    	
 
    	
109
    	
 
    
	
William   A. Fewless
    	
 
    	
105
    	
 
    
	
F.   Patrick Fonner & B. Lynne Fonner, Trustees
    	
 
    	
2,174
    	
 
    
	
Dale   N. Gehring
    	
 
    	
669
    	
 
    
	
Gerald   J. Gillis
    	
 
    	
17
    	
 
    
	
Frederick   C. Goeth, III
    	
 
    	
542
    	
 
    
	
Bal   M. Gupta
    	
 
    	
124
    	
 
    
	
Charles   B. Hagen
    	
 
    	
6
    	
 
    
	
Donald   D. Harikian
    	
 
    	
827
    	
 
    
	
John   H. Heeren
    	
 
    	
6
    	
 
    
	
Stephen   E. Herbert
    	
 
    	
268
    	
 
    
	
David   M. Hollar
    	
 
    	
76
    	
 
    
	
Gene   K. Huey
    	
 
    	
19,289
    	
 
    
	
Larry   R. Huget
    	
 
    	
12,323
    	
 
    
	
Matthew   A. Huget
    	
 
    	
1,000
    	
 
    
	
Matthew   Adam Huget, Trustee of the Matthew Huget Trust dtd 7/21/07
    	
 
    	
2,000
    	
 
    
	
Peter   J. Huget
    	
 
    	
1,000
    	
 
    
	
Peter   Jason Huget, Trustee of the Peter Huget Trust dtd 7/21/07
    	
 
    	
2,000
    	
 
    
	
Raymond   G. W. Inkster
    	
 
    	
62
    	
 
    
	
Michael   R. Jubinville
    	
 
    	
128
    	
 
    
	
Francis   Jungers, Trustee of the Francis Jungers Trust U/A dtd 11/13/03
    	
 
    	
2,101
    	
 
    
	
Frank   Jungers
    	
 
    	
503
    	
 
    
	
Jeffrey   W. Kershaw
    	
 
    	
1,362
    	
 
    
	
Elizabeth   M. King
    	
 
    	
275
    	
 
    
	
Elizabeth   Mary King or the successors
    	
 
    	
261
    	
 
    
	
Grant   L. Kleckner
    	
 
    	
598
    	
 
    

 

 

	
John   S. Kreitzberg
    	
 
    	
1,032
    	
 
    
	
Daniel   A. Kucera
    	
 
    	
599
    	
 
    
	
Aaron   B. Lian
    	
 
    	
20
    	
 
    
	
Amy   T. Lian
    	
 
    	
53
    	
 
    
	
James   H. Liberator
    	
 
    	
372
    	
 
    
	
John   F. Lymp
    	
 
    	
57
    	
 
    
	
Douglas   H. MacGowan
    	
 
    	
958
    	
 
    
	
Douglas   E. Malkasian
    	
 
    	
1,220
    	
 
    
	
Mark   Mallory
    	
 
    	
1,897
    	
 
    
	
Steven   McCall
    	
 
    	
256
    	
 
    
	
Larry   E. McCoy
    	
 
    	
1,825
    	
 
    
	
Kenneth   W. Meyer
    	
 
    	
457
    	
 
    
	
William   R. Miner
    	
 
    	
15
    	
 
    
	
Timothy   B. Myers
    	
 
    	
1,887
    	
 
    
	
Brian   L. Neilson
    	
 
    	
13
    	
 
    
	
Hung   C. Ngyuen
    	
 
    	
600
    	
 
    
	
Christopher   S. Ohland
    	
 
    	
42
    	
 
    
	
John   B. O’Neill
    	
 
    	
1,138
    	
 
    
	
Jon   V. Owens
    	
 
    	
2,040
    	
 
    
	
Juan   C. Parra
    	
 
    	
256
    	
 
    
	
Janet   Hahn Peterson
    	
 
    	
470
    	
 
    
	
Alan   Phillips
    	
 
    	
628
    	
 
    
	
Steven   A. Pickering
    	
 
    	
3,332
    	
 
    
	
Douglas   K. Pierce
    	
 
    	
137
    	
 
    
	
Daniel   W. Pizzuto
    	
 
    	
251
    	
 
    
	
Herbert   S. Plep
    	
 
    	
64
    	
 
    
	
David   L. Poer
    	
 
    	
214
    	
 
    
	
Paul   W. Pope
    	
 
    	
1,132
    	
 
    
	
William   H. Prather
    	
 
    	
643
    	
 
    
	
Steven   D. Pratt
    	
 
    	
22,961
    	
 
    
	
Phoa   Ang Pueh
    	
 
    	
85
    	
 
    
	
Jeffry   J. Ratkowski
    	
 
    	
62
    	
 
    

 

 

	
Richard   G. Reiten
    	
 
    	
641
    	
 
    
	
James   P. Richards
    	
 
    	
237
    	
 
    
	
Allen   D. Robinson
    	
 
    	
43
    	
 
    
	
James   A. Rowzee
    	
 
    	
423
    	
 
    
	
Stephen   S. Salinero
    	
 
    	
6
    	
 
    
	
Reza H. I. Sara
    	
 
    	
229
    	
 
    
	
Steven   P. Schad
    	
 
    	
538
    	
 
    
	
Scott   H. Seiffert
    	
 
    	
424
    	
 
    
	
Ermanno   Simonutti
    	
 
    	
154
    	
 
    
	
Joe   D. Smith
    	
 
    	
385
    	
 
    
	
James   E. Snook
    	
 
    	
855
    	
 
    
	
James   Edward Songer
    	
 
    	
2,606
    	
 
    
	
Robert   M. Stayton
    	
 
    	
30
    	
 
    
	
Raymond   P. Sykes
    	
 
    	
2,013
    	
 
    
	
John   B. Thomas
    	
 
    	
342
    	
 
    
	
Ray   Verlinich
    	
 
    	
1,366
    	
 
    
	
Jodi   Walder-Biesanz
    	
 
    	
463
    	
 
    
	
Charlie   E. Walker
    	
 
    	
71
    	
 
    
	
Robert   C. Warren
    	
 
    	
20,458
    	
 
    
	
J.   Carter Webb
    	
 
    	
57
    	
 
    
	
Joseph   T. Weber
    	
 
    	
1,741
    	
 
    
	
William   A. Weber, Jr.
    	
 
    	
1,643
    	
 
    
	
James   P. Whalen
    	
 
    	
584
    	
 
    
	
Craig   D. Wihtol
    	
 
    	
342
    	
 
    
	
John   W. Wood, Jr.
    	
 
    	
76
    	
 
    
	
John   W. Wood, Jr. or his successors as Trustee of the John W. Wood, Jr.   Revocable Trust of 2008 
    	
 
    	
1,069
    	
 
    

 

 

ESCO Corporation

Termination of Restated Stock Transfer Restriction Agreement

 

This Agreement is between ESCO Corporation (the “Company”) and the undersigned shareholder of the Company (the “Shareholder”).

 

Recitals

 

1.  The Shareholder and the Company are parties to the Restated Stock Transfer Restriction Agreement relating to shares of common stock of the Company held by the Shareholder.

 

2.  The Company filed a Registration Statement on Form S-1 with the Securities and Exchange Commission relating to the public offering of common stock of the Company (the “IPO”).

 

3.  The Company and the Shareholder desire to terminate the Restated Stock Transfer Restriction Agreement upon the closing of the IPO, including terminating provisions that (i) restrict the transfer of shares by the Shareholder and (ii) require or permit the Company to repurchase shares from the Shareholder in specified circumstances.

 

Agreement

 

The Shareholder and the Company agree that, effective on the closing of the IPO, the Restated Stock Transfer Restriction Agreement between the Company and the Shareholder is terminated in its entirety.

 

Shareholder

 

	
 
    	
 
    	
 
    	
Date:
    	
 
    
	
(Signature)
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
(Print   name)
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
ESCO Corporation
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
By:
    	
 
    	
 
    	
Date:
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
Title:
    	
 
    	
 
    	
 
    	
 
    
							

 

CONSENT OF SPOUSE

 

The undersigned spouse of Shareholder has read and approves the foregoing agreement. The undersigned agrees to be irrevocably bound by the agreement and further agrees that any community interest will be similarly bound by the agreement.

 

	
 
    	
 
    
	
 
    	
Spouse   of Shareholder
    

 

 

ESCO CORPORATION

RESTATED STOCK TRANSFER RESTRICTION AGREEMENT
  (Class A Common Stock)

 

This Restated Stock Transfer Restriction Agreement (“Agreement”), effective as of                              is by and between ESCO Corporation, an Oregon corporation (the “Company”), and the shareholder whose name appears on the signature page below (“Shareholder”).

 

RECITALS

 

A.                                   Prior to the effective date of the Agreement, Shareholder owns or has options to purchase shares of the Company’s Class A Common Stock or expects to acquire Class A Common Stock in connection with the stock reclassifications contemplated by the Second Restated Articles of Incorporation of the Company.

 

B.                                     Prior to the effective date of the Agreement, the Company and Shareholder are parties to one or both of the Stock Transfer Restriction Agreement and the Stock Purchase Agreement (Restated) (collectively, the “Prior Agreements”) relating to shares of stock of the Company owned by Shareholder.  Shareholder desires to amend and restate in its entirety one or more Prior Agreements.

 

C.                                     The Company and Shareholder intend for the Agreement to be effective upon, and subject to, the sale of Class C Preferred Stock to the ESCO Corporation Employee Stock Ownership Plan contemplated by the Second Restated Articles of Incorporation of the Company.

 

AGREEMENT

 

1.                                       Limitations on Transfer.

 

1.1 Shares Subject to Restrictions Under This Agreement. For purposes of this Agreement, the term “Shares” means all of the shares of the Company’s Class A Common Stock owned or held by Shareholder, including any additional shares that may be acquired subsequent to the date of this Agreement and all securities received in replacement of Class A Common Stock or as stock dividends or splits and all securities received in replacement of Class A Common Stock in a recapitalization, merger, or other reorganization, except as otherwise provided in Schedule A.

 

1.2 Restrictions. In addition to any other limitation on transfer created by applicable securities laws, by the Company’s Articles of Incorporation or Bylaws, or by a separate agreement between the Company and Shareholder, Shareholder may not sell or otherwise transfer, including transfers by gift and by operation of law, any interest in any of the Shares except as provided in this Agreement. Any transfer of the Shares in violation of this Agreement will be void. All certificates representing any of the Shares will contain a legend referring to the restrictions in this Agreement.

 

 

1.3 Permitted Family Transfer. Nothing contained herein will be deemed to prevent Shareholder from effecting a transfer to, or for the benefit of, a Shareholder’s spouse, lineal descendant, or ancestor, or a trust established solely for the benefit of one or more of the foregoing. Shareholder will give the Company notice in writing at least 30 days before effecting such transfer, setting forth the name of the proposed transferee, the relationship of such transferee to the Shareholder, and the number of Shares to be transferred to such transferee. Any transfer of Shares under this provision will be subject to the transferee agreeing in writing to be bound by all of the terms and conditions of this Agreement, including the provisions of Sections 2, 3 and 4.

 

2.                                       Company Right of First Refusal. If Shareholder desires (or is required) to sell or transfer any of the Shares in any manner other than pursuant to Sections 1.3, 3 or 4, Shareholder must first obtain a firm, unconditional written offer signed by a bona fide prospective purchaser (the “Bona Fide Offer”), stating the number of Shares to be purchased, the total purchase price, and the terms of payment of the purchase price. Shareholder will mail a copy of the Bona Fide Offer to the Company. For a period of 60 days following the Company’s receipt of a copy of the Bona Fide Offer (the “Refusal Period”), the Company will have a right of first refusal to purchase any portion of the Shares covered by the Bona Fide Offer at the same price, and upon the same terms (or terms as similar as reasonably possible) set forth in the Bona Fide Offer. If the Shares are not purchased by the Company by the end of the Refusal Period, the selling Shareholder will have 60 days (the “Transfer Period”) following lapse of the Refusal Period to dispose of the Shares to the transferee identified in the Bona Fide Offer on terms no more favorable to the transferee than those offered to the Company. After the Transfer Period lapses, the Shares will once again be subject to the rights of first refusal contained in this Section 2.  Any transfer of Shares under the provisions of this Section 2 shall be subject to the transferee agreeing in writing that following the transfer (a) the provisions of this Section 2 shall continue to apply to the Shares, (b) the Put Options set forth in Section 3 shall not apply to the Shares and (c) the Call Option set forth in Section 4 shall apply when the Shareholder transferor leaves the service of the Company for any reason (including death, retirement, disability, termination by the Company or voluntary termination by the Shareholder transferor) even though the Shareholder transferor no longer owns the Shares.

 

3.                                       Put Option.

 

3.1 Availability.  Upon Shareholder’s retirement, death or disability (each a “Triggering Event”), Shareholder or Shareholder’s personal representative or other successor in interest (“Successor”), as the case may be, may require the Company to repurchase all or any portion of the Shares held by Shareholder or Shareholder’s Successor (the “Put Option”) in accordance with the terms of this Section 3;  provided, however, that if a Triggering Event occurs prior to December 26, 2008, such Triggering Event shall, for purposes of this Agreement, be deemed to occur as of December 26, 2008.  The term “disability” means a mental or physical impairment which occurs while Shareholder is an employee of the Company or any subsidiary of the Company and which is expected to result in death or which has lasted or is expected to last for a continuous period of 12 

 

2

 

months or more and which causes the Shareholder to be unable, in the opinion of the Company, to perform his or her duties as an employee, director, officer or consultant of the Company.  Disability shall be deemed to have occurred on the first day after the Company has made a determination of disability.  The term “retirement” means, for employees, retirement from ESCO at normal retirement age (65) or earlier in the Company’s sole discretion, and for directors, discontinuation of service as a member of the Board of Directors.

 

3.2 Price and Procedure.  The purchase price for any Shares purchased pursuant to this Section 3 shall be the fair market value of the Shares as of the last day of the fiscal quarter immediately preceding the quarter in which the Triggering Event occurs (or is deemed to occur) or in which the applicable anniversary of the Triggering Event occurs as specified in Section 3.3, 3.4 or 3.6.2 (the “Valuation Date”), which value shall be fixed by the Board of Directors (or a committee of the Board of Directors) at a value consistent with the valuation undertaken for purposes of the ESCO Corporation Employees’ Stock Ownership Plan as of the Valuation Date.  Each Put Option shall be exercised by written notice to the Company (the “Put Notice”), which must be given by the Shareholder to the Company within 90 days of the date the Triggering Event (or applicable anniversary of the Triggering Event) occurs (the “Put Option Election Period”). The Put Notice shall specify the number of Shares to be purchased and a date for closing (the “Closing Date”), which shall not be less than 45 days and not more than 60 days after expiration of the Put Option Election Period.  The Company shall regularly provide quarterly valuations of the Class A Common Stock to Shareholder.

 

3.3 Retirement or Disability.  Upon retirement or disability, each Shareholder shall have a right to sell to the Company a portion or all Shares held by that Shareholder over a three-year period.  Beginning in 2009, upon retirement or disability Shareholder shall have the opportunity to exercise Shareholder’s Put Option for up to 1/3 of the Shares held by Shareholder as of the date of retirement or disability.  On the first anniversary of the retirement or disability, Shareholder shall have the opportunity to exercise Shareholder’s Put Option for between 1/3 and 2/3 of the Shares held by Shareholder as of the date of retirement or disability.  On the second anniversary of the date of the retirement or disability, Shareholder shall have the opportunity to exercise Shareholder’s Put Option as to any remaining Shares.  For Put Option exercises by Shareholder in any year with a purchase price not exceeding $1 million, the Company shall pay the total purchase price on the applicable Closing Date for the exercise of the Put Option.  For Put Option exercises by Shareholder in any year with a purchase price exceeding $1 million, the Company may, at its option, pay $1 million on the applicable Closing Date for the exercise of the Put Option, and 1/2 of the remaining amount on each of the first and second anniversaries of the Triggering Event.

 

3.4 Death.  Beginning in 2009, upon the death of Shareholder, Shareholder’s Successor shall have the opportunity to exercise the Put Option for up to 1/2 of the Shares held by Shareholder on the date of death.  On the first anniversary of the date of death, Shareholder’s Successor shall have the opportunity to exercise the Put Option as 

 

3

 

to any remaining Shares.  For a Put Option exercise in one year for more than 1/2 of the Shares held by Shareholder as of the date of death, the Company may, at its option, pay the repurchase price in two equal annual installments, with the first installment payable on the Closing Date the exercise of the Put Option and the remaining amount payable on the first anniversary of that Closing Date.  For a Put Option exercise with respect to up to 1/2 of the Shares held by Shareholder as of the date of death, the Company shall pay the purchase price total at the applicable Closing Date.

 

3.5 Interest Rate.  For purposes of Sections 3.3 and 3.4 hereof, the deferred portion of the purchase price shall bear interest at the Wall Street Journal Prime Rate on the first day of the calendar year in which the closing occurs.

 

3.6 Repurchase Limitations.  Notwithstanding any provision in this Agreement, the Company shall not be obligated to repurchase any shares pursuant to Section 3 in the event that any limitation set forth in this Section 3.6 (the “Repurchase Limitations”) is applicable.

 

3.6.1  Corporate Law Restrictions and Covenant Limitations.  The Company shall not be required to repurchase any Shares pursuant to Section 3 if the repurchase would cause the Company to be in violation of (i) the statutory solvency and balance sheet tests of ORS 60.181 governing distribution limits or any other provisions of the corporate law of Oregon, or (ii) the terms, conditions or covenants of any of the Company’s outstanding credit agreements.

 

3.6.2 Deferral of Put Options.  In the event any Repurchase Limitation is applicable and the Company does not repurchase Shares pursuant to the exercise of Put Options by Shareholder or Shareholder’s Successor, Shareholder or Shareholder’s Successor shall have the right to exercise the Put Options with respect to such Shares that could not be respurchased due to a Purchase Limitation in the first fiscal quarter in which the repurchase can be made without violation of the Repurchase Limitations.  In the event of any deferral of Put Options, the Company shall notify Shareholder or Shareholder’s Successor of the applicable Put Option Election Period.  With respect to any deferral of Put Options by reason of the Repurchase Limitations, the purchase price shall be determined as of the last day of the fiscal quarter preceding the quarter in which the repurchase occurs.

 

3.6.3  Allocation.  Shareholder understands that other shareholders have contractual Put Options with respect to their shares (“Other Shareholders”).  The Company will consider the Put Options of other shareholders (and any other stock repurchases that the Company makes pursuant to contracts or otherwise) in determining whether the Repurchase Limitations will limit the ability of the Company to repurchase Shares from Shareholder.  In the event that in any year the Repurchase Limitations permit some shares to be purchased from Shareholder and Other Shareholders but do not permit the repurchase of all shares as to which 

 

4

 

Shareholder and the Other Shareholders desire to exercise Put Options or other repurchase rights, the Company shall repurchase shares according to the following priorities:

 

(i)  Subject to (iv) below, shares will next be repurchased from Shareholder’s Successor and Other Shareholders’ successors due to the death of Shareholder or Other Shareholders, and if not all shares may be repurchased due to the Repurchase Limitations, shares will be repurchased from Shareholder’s Successor and the other shareholders’ successors on a prorata basis (based on the number of shares as to which a shareholder’s Put Options apply in such year in relation to the total number of shares as to which Put Options held in the aggregate by Shareholder and Other Shareholders apply in such year);

 

(ii)  If additional shares can be repurchased pursuant to the Repurchase Limitations, shares will next be repurchased from Shareholder and Other Shareholders due to the disability of Shareholder or Other Shareholders, and if not all shares may be purchased due to the Repurchase Limitations, shares will be repurchased from Shareholder and the Other Shareholders on a prorata basis (based on the number of shares as to which the Put Options apply in such year in relation to the total number of shares as to which Put Options held in the aggregate by Shareholder and Other Shareholders apply in such year);

 

(iii)  If additional shares can be repurchased pursuant to the Repurchase Limitations, shares will next be repurchased from Shareholder and Other Shareholders due to the retirement of Shareholder or Other Shareholders, and if not all shares may be purchased due to the Repurchase Limitations, shares will be repurchased from Shareholder and the Other Shareholders on a prorata basis (based on the number of shares as to which the Put Options apply in such year in relation to the total number of shares as to which Put Options held in the aggregate by Shareholder and Other Shareholders apply in such year); and

 

(iv) If the Repurchase Limitations limit repurchases in any year, in the next year, any shares held by Shareholder or Other Shareholders that could not be repurchased shall first be repurchased in the following year in which repurchases can be made under the Repurchase Limitations (before any other shares shall be repurchased under the above priorities), and if all such shares cannot be repurchased in the following year, shares will be repurchased from Shareholder and Other Shareholders on a prorata basis (based on the number of shares of a shareholder that were not repurchased in the prior year in relation to the total number of shares held in the aggregate by Shareholder and Other Shareholder that were not repurchased in the prior year).

 

5

 

4.                                       Call Option.  If a Triggering Event occurs and the Company does not receive a Put Notice with respect thereto as provided in Section 3, or receives a Put Notice as to fewer than all of the Shares held by Shareholder, the Company shall have, on the expiration of the last Put Option following retirement, disability or death, the option (the “Call Option”) to purchase any or all Shares held by Shareholder or Shareholder’s Successor on the terms and subject to the conditions of Section 3 hereof.  The Company shall have 90 days from the expiration of the last Put Option Election Period to exercise the Call Option.  In the event of the death of Shareholder, Shareholder’s Successor shall promptly inform the Company of Shareholder’s death.  If the Company is not given notice of Shareholder’s death (or receives notice after the Call Option would have otherwise expired), the Company shall have 90 days from actual notice of Shareholder’s death to exercise the Call Option.  If Shareholder leaves the service of the Company for any reason other than death, retirement or disability, the Company shall have 90 days from the date of Shareholder’s departure to require Shareholder to sell the Shares to the Company at the per share price then in effect for repurchases pursuant to Section 3.  In the event repurchases cannot be made by reason of restrictions described in Section 3.6.1, the Company’s Call Option shall apply as soon as such restrictions are no longer applicable.

 

5.                                       Assignment by the Company. The right of the Company to purchase any part of the Shares under Section 2 or Section 4 of this Agreement may be assigned in whole or in part to any person or persons designated by the Board of Directors of the Company.

 

6.                                            Obligations Binding Upon Transferees. Except as otherwise provided in Section 2, All transferees of Shares or any interest therein will receive and hold such Shares or interests subject to the provisions of this Agreement. Any sale or transfer of the Shares will be void unless the provisions of this Agreement are met.

 

7.                                       Termination. This Agreement will terminate on the earlier of (i) the closing of an underwritten public offering of Class A Common Stock of the Company or (ii) the closing date of a sale of assets or merger of the Company pursuant to which shareholders of the Company receive securities of a buyer whose shares are publicly traded.

 

8.                                       Transfers in Violation. The Company will not be required to (a) transfer on its books any Shares that have been sold or transferred in violation of any of the provisions set forth in this Agreement, or (b) treat as owner of such Shares, or accord the right to vote as such owner, or pay dividends to any transferee to whom such Shares are purported to have been so transferred.

 

9.                                       Enforcement. The Company and Shareholder acknowledge that the other party will suffer irreparable harm if either party fails to comply with this Agreement, and that monetary damages will be inadequate to compensate the parties for such failure. Accordingly, the parties agree that this Agreement may be enforced by specific 

 

6

 

performance or other injunctive relief, in addition to any other remedies available at law or in equity.

 

10.                                 Governing Law. This Agreement will be governed by, and will be construed and enforced in accordance with, the laws of the state of Oregon.

 

11.                                      Miscellaneous.

 

11.1 Shareholder Rights. Subject to the provisions and limitations hereof, Shareholder may, during the term of this Agreement, exercise all rights and privileges of a shareholder of the Company with respect to the Shares.

 

11.2 Notices. Any notice, demand, or request required or permitted to be given under this Agreement must be in writing and will be deemed given when delivered personally, or three days after being deposited in the United States mail as certified or registered mail, return receipt requested, with postage prepaid, or the day following facsimile transmission, with confirmed transmission, in either case addressed, if to the Company, to it at the address shown below its signature; and if to Shareholder, at Shareholder’s address shown on the stock records of the Company, or at such other address as any party may designate by 10 days’ advance written notice to the other party.

 

11.3 Amendment; Waiver. Except as provided in Section 11.7, this Agreement may be amended only by the written consent of the Company and Shareholder. No waiver of any provision of this Agreement will be effective unless in writing and signed by the waiving party.

 

11.4 Assignment. The rights and benefits of this Agreement will inure to the benefit of and be enforceable by the Company and its respective successors and assigns. Except as otherwise provided herein, the rights and obligations of Shareholder under this Agreement may not be assigned without the prior written consent of the Company.

 

11.5 Attorneys’ Fees. If suit or action is filed by any party to enforce this Agreement or otherwise with respect to the subject matter of this Agreement, the prevailing party will be entitled to recover reasonable attorneys’ fees and expenses incurred in preparation for and prosecution of such suit or action at trial, on appeal, and in connection with any petition for review.

 

11.6 Effective Date; Effect on Prior Agreements.  This Agreement shall be effective upon, and subject to, the sale of Class C Preferred Stock to the ESCO Corporation Employee Stock Ownership Plan contemplated by the Second Restated Articles of Incorporation of the Company.  In the event that such sale does not occur by December 31, 2006, this Agreement shall be of no effect and the Prior Agreements shall remain in effect.  Upon the effective date of this Agreement, this Agreement shall supersede and replace the Prior Agreements, except as otherwise provided in Schedule A.

 

7

 

11.7  Section 409A. This Agreement is intended to comply with the provisions of Section 409A the Internal Revenue Code of 1986, as amended, and shall be interpreted in accordance with Section 409A and Treasury regulations and other interpretive guidance issued thereunder.  If the Company at any time determines that this Agreement would cause or may cause any arrangement between the Company and Shareholder to be nonqualified deferred compensation subject to Section 409A, the Company may amend this Agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Company determines to be necessary or appropriate to (a) allow the arrangement not to be subject to Section 409A, or (b) comply with the requirements of Section 409A.

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

 

	
SHAREHOLDER:
    	
 
    	
ESCO   CORPORATION
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Name:
    	
 
    
	
 
    	
 
    	
Title:
    	
 
    
	
 
    	
 
    	
 
    
	
Address:
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
						

 

8

 

CONSENT OF SPOUSE

 

The undersigned spouse of Shareholder has read and hereby approves the foregoing Agreement. The undersigned hereby agrees to be irrevocably bound by the Agreement and further agrees that any community interest will be similarly bound by the Agreement. I hereby appoint my spouse as my attorney-in-fact with respect to any amendment or exercise of any rights under the Agreement.

 

 

	
 
    	
 
    
	
 
    	
Spouse of Shareholder
    

 

9

 

Schedule A

 

Not Applicable

 

 

Schedule A

 

[The following will be added if a Shareholder holds Class A Common Stock and Class A Preferred Stock before the reclassifications and elects to have the existing Stock Purchase Agreement (Restated) continue to apply to the Class A Common Shares received upon the reclassification of the Shareholder’s Class A Preferred Stock:

 

Shareholder and the Company agree that this Agreement shall not apply to shares of Class A Common Stock of the Company that Shareholder acquired pursuant to the Restated Articles upon the reclassification of shares of Class A Preferred Stock held by Shareholder.  With respect to these shares of Class A Common Stock, the Stock Purchase Agreement (Restated) between the Company and Shareholder shall continue to apply.]Exhibit 10.10

 

As of March 1, 2012, agreements substantially in the form attached for the performance period 2011-2013 with applicable performance measures have been entered into between the Company and the following Named Executive Officers:

 

	
Name
    	
 
    	
Target Share Amount
    	
 
    
	
Steven D. Pratt
    	
 
    	
995
    	
 
    
	
Calvin W. Collins
    	
 
    	
419
    	
 
    
	
Ray Verlinich
    	
 
    	
144
    	
 
    
	
Gene K. Huey
    	
 
    	
365
    	
 
    
	
Nicholas L. Blauwiekel
    	
 
    	
153
    	
 
    
	
Francois Baril
    	
 
    	
162
    	
 
    

 

Performance targets are based on cash flow and sales growth over 2011, 2012 and 2013. The table below indicates the performance measure for each criterion required to achieve payouts at the end of the three-year period at the threshold, target and maximum levels.

 

	
Performance
   Criteria
    	
 
    	
Weighting (% of
   target
   award subject to
   each criteria)
    	
 
    	
Performance for
   60%
   Threshold Award
   Payout
    	
 
    	
Performance for
   100%
   Target Award
   Payout
    	
 
    	
Performance for
   300%
   Maximum Award
   Payout
    	
 
    
	
Cash Flow (1)
    	
 
    	
40
    	
%
    	
$
    	
285,800,000
    	
 
    	
$
    	
302,500,000
    	
 
    	
$
    	
330,900,000
    	
 
    
	
Net Sales Growth (2)
    	
 
    	
60
    	
%
    	
$
    	
289,900,000
    	
 
    	
$
    	
377,600,000
    	
 
    	
$
    	
491,900,000
    	
 
    

 

(1)                                 Cash flow for the performance period is equal to the sum of the Company’s operating profit for each year in the performance period less the change in net working capital over the performance period. Net working capital is trade accounts receivables plus inventories minus accounts payable.

 

(2)                                 Net Sales Growth for the performance period is equal to the net sales for the year ending December 31, 2013 minus net sales for the year ended December 31, 2010.

 

At the end of the performance period, if at least one performance goal has been achieved at the threshold level of performance or above, a participant would receive shares of Legacy Class A Common Stock. The number of shares received depends on the level of achievement of the performance goals, with the maximum number of shares equal to the number of target shares for the participant multiplied by three.

 

 

Agreements substantially in the form attached have been entered into between the Company and Named Executive Officers with appropriate changes to reflect:

 

·      Name

·      Date

·      Performance Period

·      Target Share Amount

·      Performance Measures

 

 

ESCO CORPORATION

PERFORMANCE UNIT AWARD AGREEMENT

(For Grants after 2010)

 

This Agreement is entered into as of              between ESCO Corporation, an Oregon corporation (the “Company”), and                           (“Recipient”).

 

On           , the Company’s Board of Directors (the “Board”) authorized the grant of performance units to Recipient pursuant to Section 9 of the Company’s 2010 Stock Incentive Plan (the “Plan”). Recipient desires to accept the award subject to the terms and conditions of this Agreement.

 

NOW, THEREFORE, the parties agree as follows:

 

1.             Award.   Subject to the terms and conditions of this Agreement, the Company shall issue to Recipient the number of shares of Class A Common Stock of the Company (“Performance Shares”) determined under this Agreement based on (a) the performance of the Company during the three-year period from January 1,          to December 31,            (the “Performance Period”) as described in Section 2, and (b) Recipient’s continued employment during the Performance Period as described in Section 3. Recipient’s “Target Share Amount” for purposes of this Agreement is                  shares.

 

2.             Performance Conditions.

 

2.1          Payout Factor.     Subject to adjustment under Sections 3, 4, 5 and 6, the number of Performance Shares to be issued to Recipient shall be determined by multiplying the Payout Factor by the Target Share Amount. The “Payout Factor” shall be equal to the sum of (a) 40% of the Cash Flow Payout Factor as determined under Section 2.2 below, plus (b) 60% of the Revenue Growth Payout Factor as determined under Section 2.3 below.

 

2.2          Cash Flow Payout Factor.

 

2.2.1       The “Cash Flow Payout Factor” shall be determined under the table below based on the Cash Flow (as defined in Section 2.2.2) of the Company for the Performance Period.

 

	
Cash Flow
    	
 
    	
Payout Factor
    	
 
    
	
Less than $              
    	
 
    	
0
    	
%
    
	
$            (threshold)
    	
 
    	
60
    	
%
    
	
$            (target)
    	
 
    	
100
    	
%
    
	
$              and   above (maximum)
    	
 
    	
300
    	
%
    

 

 

If the Cash Flow is between any two data points set forth in the first column of the above table, the Cash Flow Payout Factor shall be determined by interpolation between the corresponding data points in the second column of the table as follows: the difference between the Cash Flow and the next lower data point in the first column shall be divided by the difference between the next higher data point and the next lower data point in the first column, the resulting fraction shall be multiplied by the difference between the two corresponding data points in the second column of the table, and the resulting product shall be added to the lower corresponding data point in the second column of the table, with the resulting sum being the Cash Flow Payout Factor.

 

2.2.2       The Company’s “Cash Flow” for the Performance Period shall be equal to Cumulative Operating Profit less the “Change in Net Working Capital” over the Performance Period.  “Cumulative Operating Profit” shall be the sum of consolidated operating profit for each year in the Performance Period as reflected in the Company’s audited financial statements. “Change in Net Working Capital” means Net Working Capital at the end of the Performance Period less Net Working Capital at the beginning of the Performance Period.  “Net Working Capital” as of a specified date means the Company’s trade accounts receivables plus inventories less accounts payables, as those amounts are reflected in the Company’s consolidated audited financial statements as of that same date.

 

2.3          Revenue Growth Payout Factor.

 

2.3.1       The “Revenue Growth Payout Factor” shall be determined under the table below based on the Revenue Growth of the Company for the Performance Period.

 

	
Period Ending Revenue
    	
 
    	
Revenue Growth
    	
 
    	
Payout Factor
    	
 
    
	
Less than $            
    	
 
    	
Less than $            
    	
 
    	
0
    	
%
    
	
$            (threshold)
    	
 
    	
$              
    	
 
    	
60
    	
%
    
	
$            (target)
    	
 
    	
$             
    	
 
    	
100
    	
%
    
	
$              and   above (maximum)
    	
 
    	
$              and above
    	
 
    	
300
    	
%
    

 

If the Revenue Growth is between any two data points set forth in the second column of the above table, the Revenue Growth Payout Factor shall be determined by interpolation between the corresponding data points in the third column of the table as follows: the difference between the Revenue Growth and the next lower data point shall be divided by the difference between the next higher data point and the next lower data point, the resulting fraction shall be multiplied by the difference between the two corresponding data points in the third column of the table, and the resulting product

 

2

 

shall be added to the lower corresponding data point in the third column of the table, with the resulting sum being the Revenue Growth Payout Factor.

 

2.3.2       The Company’s “Revenue Growth” for the Performance Period is equal to the net sales for the year ended December 31,         minus net sales for the year ended December 31,         , as net sales are reflected in the Company’s consolidated audited financial statements for those same periods.

 

2.4          Adjustments.   Adjustments to the Cash Flow and Revenue Growth performance measures set forth in Sections 2.2 and 2.3 for actual results under the performance measures for the three-year Performance Period may be made in the event of the occurrence of extraordinary or non-recurring circumstances that, in the sole judgment of the Board of Directors, would cause the application of the existing performance goals or measures to fail to fairly reflect the performance of the Company. These circumstances may include acquisitions, divestitures, joint ventures, regulatory developments, tax law changes, accounting changes, restructuring or other special charges, or other occurrences. Adjustments will be made as soon as practicable following the occurrence of the circumstance, or, at the discretion of the Board of Directors, following the end of the Performance Period.

 

3.             Employment Condition.

 

3.1          Payout.                  In order to receive any award under this Agreement, Recipient must be employed by the Company on December 31,          (the “Vesting Date”), except as provided by Sections 3.2, 3.3, 3.4, 3.5 and 4.

 

3.2          Retirement.           If Recipient’s employment with the Company is terminated at any time prior to the Vesting Date because of retirement (defined as retirement from the Company or a subsidiary at normal retirement age sixty five (65) or earlier at the Company’s sole discretion), Recipient shall be entitled to receive a pro-rated award following completion of the Performance Period. The number of Performance Shares to be issued as a pro-rated award under this Section 3.2 shall be determined by multiplying the number of Performance Shares determined under Section 2 by a fraction, the numerator of which is the number of days Recipient was employed by the Company since the beginning of the Performance Period and the denominator of which is 1095. Any obligation of the Company to pay a pro-rated award under this Section 3.2 shall be subject to and conditioned upon the execution and delivery by Recipient of a Release of Claims in such form as may be requested by the Company.

 

3.3          Total Disability.    If Recipient’s employment with the Company is terminated at any time prior to the Vesting Date because of total disability (as defined in paragraph 6.1-4(b) of the Plan), Recipient shall be entitled to receive a pro-rated award following completion of the Performance Period. The number of Performance Shares to be issued as a pro-rated award under this Section 3.3 shall be determined by multiplying the number of Performance Shares determined under Section 2 by a fraction, the numerator of which is the number of days Recipient was employed by the Company since the beginning of the Performance Period and the denominator of which is 1095. Any obligation of the Company to pay a pro-rated award under this Section 3.3

 

3

 

shall be subject to and conditioned upon the execution and delivery by Recipient of a Release of Claims in such form as may be requested by the Company.

 

3.4          Death.           If Recipient’s employment with the Company is terminated at any time prior to the Vesting Date because of death, Recipient’s successor in interest shall be entitled to receive a pro-rated portion of the Target Share Amount, instead of an amount calculated under Section 2. The pro-rated award under this Section 3.3 shall be determined by multiplying the Target Share Amount by a fraction, the numerator of which is the number of days Recipient was employed by the Company since the beginning of the Performance Period and the denominator of which is 1095. Any obligation of the Company to pay a pro-rated award under this Section 3.3 shall be subject to and conditioned upon the execution and delivery by Recipient’s successor of a Release of Claims in such form as may be requested by the Company and the pro-rated award will then be paid as soon as practical by the Company.

 

3.5          Other Terminations.            If Recipient’s employment by the Company is terminated at any time prior to the Vesting Date and none of Sections 3.2, 3.3 or 3.4 applies to such termination, Recipient shall not be entitled to receive any Performance Shares under this Agreement.

 

4.             Company Sale.    If a Company Sale (as defined in this Section 4) occurs before the Vesting Date, Recipient shall be entitled to receive an award payout no later than the earlier of thirty (30) days following such event or the last day on which the Performance Shares could be issued so that Recipient may participate as a shareholder in receiving proceeds from the Company Sale.  The amount of the award under this Section 4 shall be the amount determined using a Payout Factor equal to the greater of (a) 100%, or (b) the Payout Factor calculated as if the Performance Period ended on the last day of the Company’s most recently completed fiscal quarter prior to the date of the Company Sale. For this purpose, the Cash Flow and Revenue Growth target amounts and the related Cash Flow and Revenue Growth Payout Factors in the tables in Section 2.2 and 2.3 shall be adjusted by the Board of Directors, in its discretion to appropriately reflect the shorter performance period. For purposes of this Agreement, a “Company Sale” shall mean the occurrence of any of the following events:

 

(a) any consolidation, merger or plan of share exchange involving the Company (a “Merger”) in which the Company is not the continuing or surviving corporation or pursuant to which outstanding shares of Class A Common Stock would be converted into cash, other securities or other property; or

 

(b) any sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all, or substantially all, the assets of the Company.

 

5.             Payment.               As soon as practicable following the completion of the audit of the Company’s consolidated financial statements for the final fiscal year of the Performance Period, the Board of Directors shall approve the Payout Factor and the corresponding number of Performance Shares issuable to Recipient.  Subject to applicable tax withholding, the number of Performance Shares shall be issued to Recipient as soon as practicable following the Vesting Date, but no Performance

 

4

 

Shares shall be issued prior to approval by the Board of Directors. No fractional shares shall be issued and the number of Performance Shares deliverable shall be rounded down to the nearest whole share. In the event of the death of Recipient as described in Section 3.4 or a Company Sale as described in Section 4, each of which requires an award payout earlier than the Vesting Date, a similar process shall be followed within the time frames required by those sections.

 

6.             Tax Withholding.    Recipient acknowledges that, on the date any Performance Shares are issued to Recipient (the “Payment Date”), the Value (as defined in this Section 6) on that date of the Performance Shares will be treated as ordinary compensation income for federal and state income and FICA tax purposes, and that the Company will be required to withhold taxes on these income amounts. To satisfy the required minimum withholding amount, the Company shall withhold the number of Performance Shares having a Value equal to the minimum withholding amount.  For purposes of this Section 6, the “Value” of a Performance Share shall be equal to the fair market value of the Class A Common Stock as determined pursuant to Section 9.4 of the Plan.

 

7.             No Right to Employment.  Nothing contained in this Agreement shall confer upon Recipient any right to be employed by the Company or to continue to provide services to the Company or to interfere in any way with the right of the Company to terminate Recipient’s services at any time for any reason, with or without cause.

 

8.             Miscellaneous.

 

8.1          Entire Agreement; Amendment.       This Agreement constitutes the entire agreement of the parties with regard to the subjects hereof and may be amended only by written agreement between the Company and Recipient.

 

8.2          Notices.     Any notice required or permitted under this Agreement shall be in writing and shall be deemed sufficient when delivered personally to the party to whom it is addressed or when deposited into the United States Mail as registered or certified mail, return receipt requested, postage prepaid, addressed to the Company, Attention: Corporate Secretary, at its principal executive offices or to Recipient at the address of Recipient in the Company’s records, or at such other address as such party may designate by ten (10) days’ advance written notice to the other party.

 

8.3          Assignment; Rights and Benefits.    Recipient shall not assign this Agreement or any rights hereunder to any other party or parties without the prior written consent of the Company. The rights and benefits of this Agreement shall inure to the benefit of and be enforceable by the Company’s successors and assigns and, subject to the foregoing restriction on assignment, be binding upon Recipient’s heirs, executors, administrators, successors and assigns.

 

5

 

8.4          Further Action.     The parties agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

 

8.5          Applicable Law; Attorneys’ Fees.    The terms and conditions of this Agreement shall be governed by the laws of the State of Oregon. In the event either party institutes litigation hereunder, the prevailing party shall be entitled to reasonable attorneys’ fees to be set by the trial court and, upon any appeal, the appellate court.

 

8.6          Counterparts.       This Agreement may be executed in two or more counterparts, each of which shall be deemed an original.

 

	
 
    	
ESCO   CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By   
    	
 
    
	
 
    	
Title:   
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
RECIPIENT
    
	
 
    	
 
    
	
 
    	
 
    
				

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]